Adjusted hazard ratios varied from 0.69 to 0.28 across increasing activity categories compared with 0 to 19 minutes/day
Bleeding Events Up With Full-Dose Thromboprophylaxis in COVID-19
Almost all hospitalized COVID-19 patients with a bleeding event were receiving mechanical ventilation, full-dose anticoagulation
ASA: Less Bleeding Seen With Tenecteplase for Ischemic Stroke
Rate of symptomatic intracranial hemorrhage lower with tenecteplase than the current standard medication for thrombolysis, alteplase
Atrial Shunt No Benefit for Heart Failure With Preserved EF
Subgroup analysis indicates treatment efficacy differed with presence or absence of pulmonary vascular disease unmasked by exercise